Steward Partners Investment Advisory’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.36M Sell
49,943
-159
-0.3% -$17.1K 0.04% 411
2025
Q1
$5.05M Sell
50,102
-497
-1% -$50.1K 0.04% 394
2024
Q4
$4.52M Buy
50,599
+433
+0.9% +$38.7K 0.04% 405
2024
Q3
$4.2M Sell
50,166
-10,529
-17% -$882K 0.04% 409
2024
Q2
$4.67M Buy
60,695
+1,595
+3% +$123K 0.05% 349
2024
Q1
$4.05M Buy
59,100
+33,721
+133% +$2.31M 0.04% 380
2023
Q4
$1.47M Buy
25,379
+4,127
+19% +$239K 0.02% 600
2023
Q3
$1.12M Buy
21,252
+1,088
+5% +$57.4K 0.02% 640
2023
Q2
$1.09M Sell
20,164
-5,256
-21% -$284K 0.02% 664
2023
Q1
$1.27M Sell
25,420
-2,598
-9% -$130K 0.02% 613
2022
Q4
$1.3M Buy
28,018
+1,447
+5% +$67K 0.02% 583
2022
Q3
$1.03M Sell
26,571
-1,914
-7% -$74.1K 0.02% 617
2022
Q2
$1.06M Buy
28,485
+41
+0.1% +$1.53K 0.02% 610
2022
Q1
$1.26M Sell
28,444
-2,314
-8% -$103K 0.02% 620
2021
Q4
$1.31M Buy
30,758
+534
+2% +$22.7K 0.02% 613
2021
Q3
$1.31M Sell
30,224
-353
-1% -$15.3K 0.02% 578
2021
Q2
$1.31M Sell
30,577
-9,222
-23% -$394K 0.02% 583
2021
Q1
$1.54M Buy
39,799
+12,186
+44% +$471K 0.03% 506
2020
Q4
$993K Buy
27,613
+10,322
+60% +$371K 0.02% 556
2020
Q3
$661K Buy
17,291
+1,943
+13% +$74.3K 0.02% 593
2020
Q2
$539K Buy
15,348
+3,856
+34% +$135K 0.02% 606
2020
Q1
$374K Buy
11,492
+1,744
+18% +$56.8K 0.01% 632
2019
Q4
$440K Buy
9,748
+287
+3% +$13K 0.01% 656
2019
Q3
$384K Hold
9,461
0.01% 658
2019
Q2
$406K Sell
9,461
-2,583
-21% -$111K 0.01% 610
2019
Q1
$462K Buy
12,044
+563
+5% +$21.6K 0.02% 538
2018
Q4
$405K Sell
11,481
-56
-0.5% -$1.98K 0.02% 535
2018
Q3
$444K Buy
11,537
+353
+3% +$13.6K 0.02% 532
2018
Q2
$366K Sell
11,184
-1,103
-9% -$36.1K 0.02% 531
2018
Q1
$335K Buy
12,287
+2,389
+24% +$65.1K 0.02% 502
2017
Q4
$245K Buy
9,898
+5,100
+106% +$126K 0.02% 481
2017
Q3
$139K Buy
4,798
+743
+18% +$21.5K 0.01% 492
2017
Q2
$112K Buy
+4,055
New +$112K 0.01% 477